Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression.

MLA

Quagliariello, Vincenzo, et al. “Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression.” Frontiers in Oncology, vol. 11, June 2021, p. 680758. EBSCOhost, https://doi.org/10.3389/fonc.2021.680758.

APA

Quagliariello, V., Berretta, M., Buccolo, S., Iovine, M., Paccone, A., Cavalcanti, E., Taibi, R., Montopoli, M., Botti, G., & Maurea, N. (2021). Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression. Frontiers in Oncology, 11, 680758. https://doi.org/10.3389/fonc.2021.680758

Chicago

Quagliariello, Vincenzo, Massimiliano Berretta, Simona Buccolo, Martina Iovine, Andrea Paccone, Ernesta Cavalcanti, Rosaria Taibi, Monica Montopoli, Gerardo Botti, and Nicola Maurea. 2021. “Polydatin Reduces Cardiotoxicity and Enhances the Anticancer Effects of Sunitinib by Decreasing Pro-Oxidative Stress, Pro-Inflammatory Cytokines, and NLRP3 Inflammasome Expression.” Frontiers in Oncology 11 (June): 680758. doi:10.3389/fonc.2021.680758.